Press release
Kidney Cancer Diagnostics And Therapeutics Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
Kidney Cancer Diagnostics And Therapeutics
What Is the Expected Kidney Cancer Diagnostics And Therapeutics Market Size During the Forecast Period?
The market for kidney cancer diagnostics and therapeutic treatments has experienced a significant expansion in the recent past. Predictions indicate that the market, worth $4.1 billion in 2024, will increase to $4.32 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.4%. This growth during the historical period is linked to advancements in molecular biology, breakthroughs in clinical trials and drug development, surgical progress, genetic research, and improvements in healthcare access.
The market for kidney cancer diagnostics and therapeutics is projected to witness robust growth in the coming years, reaching a value of $5.68 billion by 2029, with a compound annual growth rate (CAGR) of 7.0%. This expected growth within the forecast period is due to factors such as advancements in genomic sequencing, biomarker research, precision medicine developments, telemedicine, and quick diagnostic technologies. Key trends for this period include the integration of palliative care, emphasis on long-term survivorship care, interventions in nutrition and lifestyle, broadened application of radiomics, and the incorporation of liquid biopsies.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11937
What Are the High-Growth Segments in the Kidney Cancer Diagnostics And Therapeutics Market?
The kidney cancer diagnostics and therapeutics market covered in this report is segmented -
1) By Cancer Type: Clear Cell RCC, Papillary RCC, Chromophobe RCC, Urothelial Carcinoma And Transitional Cell Carcinoma, Other Cancer Types
2) By Component: Drugs, Diagnostics
3) By Diagnostics: Biopsy, CT Scan, Nephro-Ureteroscopy, Intravenous Pyelogram, Ultrasound
4) By Therapy: Targeted Therapy, Immunotherapy, Chemotherapy
5) By End-Users: Hospitals, Pharmaceutical Labs, Genomics Laboratories
Subsegments:
1) By Clear Cell RCC: Stage I, Stage II, Stage III, Stage IV
2) By Papillary RCC: Type 1, Type 2
3) By Chromophobe RCC: Localized, Advanced
4) By Urothelial Carcinoma And Transitional Cell Carcinoma: Non-muscle invasive, Muscle invasive, Metastatic
5) By Other Cancer Types: Collecting Duct Carcinoma, Renal Medullary Carcinoma, Other rare types
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11937&type=smp
What Key Drivers Are Expected to Influence Future Kidney Cancer Diagnostics And Therapeutics Market Growth?
The surge in kidney cancer cases is projected to enhance the expansion of the market for kidney cancer diagnostics and therapeutics. Kidney cancer, or a state where standard cells in one or both kidneys experience abnormal changes and evolve into a mass called a renal cortical tumor due to uncontrollable growth, necessitates for vital diagnostics and therapeutics. These diagnostics and therapeutics for kidney cancer are significant in disease management and treatment, offering numerous advantages such as timely discovery of the disease, precise diagnosis, treatment options, individualized medicine, and monitoring of the treatment. For example, the American Society of Clinical Oncology (ASCO), a non-profit organization based in the US dedicated to cancer care, forecasted in March 2023 that 81,800 people in the US, consisting of 52,360 males and 29,440 females, will be diagnosed with kidney cancer in 2023. Moreover, it highlighted that kidney cancer had impacted 431,288 individuals worldwide in 2020. Hence, the rising instances of kidney cancer are anticipated to stimulate the growth of the kidney cancer diagnostics and therapeutics market.
Which Companies Hold the Largest Share Across Different Kidney Cancer Diagnostics And Therapeutics Market Segments?
Major companies operating in the kidney cancer diagnostics and therapeutics market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Pharmaceuticals Limited, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Siemens Healthcare GmbH, Laboratory Corporation of America Holdings, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Eisai Co. Ltd., Illumina Inc., PerkinElmer Inc., Ipsen S.A, Bio-Rad Laboratories Inc., QIAGEN NV, Exelixis Inc., Myriad Genetics Inc., Invitae Corporation, Guardant Health Inc., GeneDx LLC, CD Genomics, Genpath Life Sciences Private Limited
What Trends Are Driving Growth in The Kidney Cancer Diagnostics And Therapeutics Market?
Leading companies engaged in the kidney cancer diagnostics and therapeutics market are concentrating on the development of sophisticated renal cell carcinoma (RCC) treatments to enhance patient advantages and provide customized treatment choices for those diagnosed with this complex illness. Efforts to research renal cell carcinoma (RCC) play a vital role in this field as they lead to the invention of innovative diagnostic techniques and tailored therapies for enhanced early detection and individual treatment. For instance, in December 2023, Merck, a pharmaceutical firm from the U.S., introduced welireg (belzutifan), the inaugural hypoxia-inducible factor-2 alpha (HIF-2a) inhibitor sanctioned for adult patients with advanced RCC after having prior treatments with PD-1 or PD-L1 inhibitors and VEGF-TKIs. This groundbreaking therapeutic class presents significant advantages, such as superior progression-free survival and higher response rates compared to everolimus. The green light for WELIREG signals a significant milestone in the kidney cancer diagnostics and therapeutics sector, creating fresh optimism for patients with progressing disease.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/kidney-cancer-diagnostics-and-therapeutics-global-market-report
What Are the Emerging Geographies for The Kidney Cancer Diagnostics And Therapeutics Market Growth?
North America was the largest region in the kidney cancer diagnostics and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney cancer diagnostics and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Kidney Cancer Diagnostics And Therapeutics Market?
2. What is the CAGR expected in the Kidney Cancer Diagnostics And Therapeutics Market?
3. What Are the Key Innovations Transforming the Kidney Cancer Diagnostics And Therapeutics Industry?
4. Which Region Is Leading the Kidney Cancer Diagnostics And Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Cancer Diagnostics And Therapeutics Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts here
News-ID: 3998350 • Views: …
More Releases from The Business Research Company
Emerging Markets And Increasing Disposable Income Fueling Diamond Market Growth: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Diamond Market Through 2025?
In the past few years, there has been a stable expansion in the diamond market size. The prediction is it will increase from $1.33 billion in 2024 to $1.39 billion in 2025, boasting a compound annual growth rate…
2025-2034 Nonmetallic Minerals Mining Support Activities Market Outlook: Key Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Nonmetallic Minerals Mining Support Activities Industry Market Size Be by 2025?
In the past few years, there has been a robust expansion in the size of the nonmetallic minerals mining support activities market. It is projected to escalate from $34.04 billion in 2024 to $36.55 billion…
Professional Street Sweeper Industry Outlook 2025-2029: Market Set to Cross $3.1 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Professional Street Sweeper Market Size By 2025?
The market size of professional street sweepers has seen significant expansion in the past few years. The market, predicted to rise from $2.37 billion in 2024 to $2.5 billion in 2025, boasts a compound annual growth rate (CAGR)…
Key Trends Reshaping the Industrial Wet Dust Collector Market: Advanced Filtrati …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Industrial Wet Dust Collector Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a robust growth in the size of the industrial wet dust collector market. It is expected to swell from $1.89 billion in 2024 to $2 billion by 2025, showing a…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
